Livio Dukaj

Livio Dukaj, PhD, is an Associate Director and Principal Scientist at TScan Therapeutics since November 2020, leading a multidisciplinary team focused on genomics, molecular cloning, and lentiviral support for discovery, pre-clinical, and translational efforts. Prior experience includes roles as a Senior Scientist and Scientist at the University of Massachusetts Medical School from April 2013 to November 2020, as well as positions as a Post-Doctoral Associate and Ph.D. Candidate in Biochemistry and Cancer Biology at the same institution from June 2010 to June 2012. Earlier in career, Livio Dukaj served as a Research Technician at the College of the Holy Cross and an Undergraduate Research Assistant with research advisor Kevin Quinn, focusing on the synthesis of biologically active compounds. Livio Dukaj holds a Ph.D. in Biochemistry and Molecular Pharmacology, Cancer Biology from UMass Chan Medical School and a Bachelor of Arts in Chemistry and Spanish from the College of the Holy Cross.